This webpage provides access to Sentinel assessments that have been conducted by U.S. FDA’s Center for Biologic Evaluation and Research (CBER). The search options below can be used to find materials based on medical product, safety outcome, and the following study types:
Search results provide a listing of assessments, reported results, related links to publications, and FDA Drug Safety Communications. If you wish to search for information on other types of projects, a comprehensive listing of all Sentinel projects, including all assessments, data, surveillance tools, methods, and communication materials can be accessed using the Report Finder.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from Sentinel in the public domain as soon as possible. Please read the disclaimer.
|Rapid Surveillance Capability Protocol: 2017-18 Seasonal Influenza Vaccines Surveillance||08/04/2017|
|Sentinel Modular Program Report: Pertussis Cases in Infants||07/27/2017|
|Modular Program Report: Tdap Vaccination During Pregnancy||07/27/2017|
|Sentinel Evaluation of the Risk of Thromboembolic Events After Immunoglobulin Administration Report||07/13/2017|
|Mini-Sentinel Thromboembolic Events After Immunoglobulin Administration Protocol||07/13/2017|
|Mini-Sentinel PRISM Influenza Vaccines and Birth Outcomes Revised Protocol||01/20/2017|
|Sentinel Modular Program Report 1: Blood transfusions||10/26/2016|
|Sentinel Modular Program Report 2: Blood transfusions||10/26/2016|
|Transfusion Related Acute Lung Injury after Red Blood Cell, Plasma and Platelet Administration 2013-2015 Protocol||09/16/2016|
|Kawasaki Disease and PCV13 Vaccine||08/15/2016|
|Mini-Sentinel PRISM Influenza Vaccines and Febrile Seizures Extension Protocol||08/01/2016|